[Oculocutaneous syndromes of toxic origin: Lyell's syndrome].
D000700:Analgesics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D003231:Conjunctivitis / Q000139:chemically induced; D003320:Corneal Ulcer / Q000139:chemically induced; D003692:Delayed-Action Preparations / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000150:complications* / Q000473:pathology; D013424:Sulfanilamides / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D000700:Analgesics; D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D006993:Hypnotics and Sedatives; D013424:Sulfanilamides; D014149:Tranquilizing Agents
Syndromes oculo-cutanés d'origine toxique: syndrome de Lyell.